The total order book of the company stood at Rs 2,120.53 crore at the end of the third quarter of FY20. Road segment constituted 63.81 per cent of this total order book.

Indian Hotels Company, on Thursday after the market hours, informed the bourses that its borrowings committee has approved the allotment of 1,500 rated, unsecured, listed, redeemable, non-convertible debentures (NCDs)

Granules India has received US Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA), Trospium Chloride extended-release capsules, 60 mg.

The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.

The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.

The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.

The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.

Railways Strategic Business Unit of L&T Construction’s Transportation Infrastructure IC in consortium with Kyosan Electric Manufacturing Co Ltd (Japan) has received a significant order in the form of three packages from Dedicated Freight Corridor Corporation of India Limited

Shilpa Medicare Limited has informed the bourses that it has launched Indian branded generic of Dasatinib, an anticancer drug with a brand name ‘Dasashil’. The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on April 12, 2020.

One of India's oldest fund houses is winding up its six debt funds. Read on to find how it will impact its investors.